Cindy Jacobs
2012
In 2012, Cindy Jacobs earned a total compensation of $950.1K as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 98% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $140,904 |
---|---|
Option Awards | $149,659 |
Salary | $391,400 |
Stock Awards | $268,125 |
Total | $950,088 |
Jacobs received $391.4K in salary, accounting for 41% of the total pay in 2012.
Jacobs also received $140.9K in non-equity incentive plan, $149.7K in option awards and $268.1K in stock awards.
Rankings
In 2012, Cindy Jacobs' compensation ranked 6,328th out of 11,487 executives tracked by ExecPay. In other words, Jacobs earned more than 44.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,328 | 45th |
Manufacturing | 2,263 | 47th |
Chemicals And Allied Products | 568 | 53rd |
Drugs | 388 | 58th |
In Vitro and In Vivo Diagnostic Substances | 18 | 62nd |
Jacobs' colleagues
We found three more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2012.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019